Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01208012 Org: User:
Start: 04/30/10 End: 11/30/10 Due: 11/30/11

Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01206647 Org: User:
Start: 02/28/10 End: 02/28/11 Due: 02/28/12

Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01206712 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01417897 Org: User:
Start: 09/30/11 End: 05/31/12 Due: 05/31/13

Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01565096 Org: User:
Start: 11/30/11 End: - Due: -

Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT02376075 Org: User:
Start: 01/31/13 End: 09/30/14 Due: 09/30/15

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

Phase: N/A Priority: Normal
NCT ID: NCT01500850 Org: User:
Start: 10/31/11 End: 10/31/12 Due: 10/31/13

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00941148 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10